STERIS plc (STE) Insider Transactions
Explore official ownership filings, with every record linked to its source.
STE · STERIS plc
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-06-01Filed 2026-06-03 | Zangerle John AdamOfficer · Sr. VP, Gen Counsel, and Sec.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 7,354 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 337D | 0 | Direct | Form 4 ↗0001628280-26-040445 |
| 2026-06-01Filed 2026-06-03 | Tamaro RenatoOfficer · V.P. & Corporate TreasurerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 81 shares were withheld from the 241 restricted shares that vested on June 1, 2026. These 81 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 1,234 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 81D | 0 | Direct | Form 4 ↗0001628280-26-040444 |
| 2026-06-01Filed 2026-06-03 | McGowan LindseyOfficer · VP, Chf. Comp. & Quality Offc.Filing contextReported filing row; may be amended. Do not sum filings blindly. F1 198 shares were withheld from the 660 restricted shares that vested on June 1, 2026. These 198 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 3,090 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. F3 Units representing 255 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 198D | 0 | Direct | Form 4 ↗0001628280-26-040443 |
| 2026-06-01Filed 2026-06-03 | Majors Cary LOfficer · SVP and President, HealthcareFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 768 shares were withheld from the 2,697 restricted shares that vested on June 1, 2026. These 768 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 7,441 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,140 on June 2, 2026; 2,379 on June 4, 2027 and 2,922 on June 5, 2028. F3 Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 768D | 0 | Direct | Form 4 ↗0001628280-26-040440 |
| 2026-06-01Filed 2026-06-03 | Madsen JuliaOfficer · Sr. VP and GM, Life SciencesFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 208D | 0 | Direct | Form 4 ↗0001628280-26-040438 |
| 2026-06-01Filed 2026-06-03 | Kohler Kenneth EOfficer · SVP & GM, ASTFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 109 shares were withheld from the 373 restricted shares that vested on June 1, 2026. These 109 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 3,141 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 630 on June 3, 2026; 513 on June 4, 2026; 630 on June 3, 2027; 513 on June 4, 2027 and 630 on June 5, 2028. F3 The shares beneficially owned were erroneously reported in prior Form 4s. The shares held are being corrected in this Form 4 to reflect the current amount of shares beneficially owned. References: F1, F2, F3 | F WithholdingOrdinary Shares · Non-derivative | 109D | 0 | Direct | Form 4 ↗0001628280-26-040436 |
| 2026-06-01Filed 2026-06-03 | Fraser Mary ClareOfficer · SVP & Chief HROFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 673 shares were withheld from the 2,313 restricted shares that vested on June 1, 2026. These 673 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 6,573 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,028 on June 2, 2026; 835 on June 3, 2026; 1,360 on June 4, 2026; 835 on June 3, 2027; 680 on June 4, 2027 and 835 on June 5, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 673D | 0 | Direct | Form 4 ↗0001628280-26-040433 |
| 2026-06-01Filed 2026-06-03 | Carestio Daniel ADirector · Officer · President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1,254 shares were withheld from the 4,308 restricted shares that vested on June 1, 2026. These 1,254 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 28,746 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 1,254D | 0 | Direct | Form 4 ↗0001628280-26-040430 |
| 2026-06-01Filed 2026-06-03 | Burton Karen LOfficer · Sr. Vice Pres., CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 99 shares were withheld from the 340 restricted shares that vested on June 1, 2026. These 99 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 As of June 1, 2026, 5,139 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 651 on June 5, 2028 and 783 on October 1, 2028. References: F1, F2 | F WithholdingOrdinary Shares · Non-derivative | 99D | 0 | Direct | Form 4 ↗0001628280-26-040426 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.